Masonic Cancer Center Articles

A portrait of Dr. Abbie Begnaud smiling on the left is juxtaposed against a graphic on the right that has a bright turquoise background with a pair of pink lungs in the middle, and a hand holding a magnifying glass examining the lungs.

Talking lung cancer awareness with Masonic Cancer Center member Dr. Abbie Begnaud

November 16, 2022
Did you know that November is National Lung Cancer Awareness Month? According to the Centers for Disease Control and Prevention, lung cancer is the leading cause of cancer death, accounting for 23 percent of all cancer deaths.
Dr. Lange

Carol Lange, PhD, receives Wall of Scholarship Award

November 8, 2022
The Wall of Scholarship, located in the Phillips-Wangensteen Building, is a physical representation of the excellent research conducted at the University of Minnesota. The Wall was founded to promote research excellence and helps inspire…
Dame Idossa

Digging Deeper Into Breast Cancer Prevention and Screening with Dr. Damé Idossa

October 17, 2022
Breast cancer is among the top five causes of death in Minnesota Women. Of those, black women have a 40% higher mortality rate than white women when it comes to breast cancer.
New logo image

New checkpoint gene demonstrates ability to supercharge immune cells against cancer

September 15, 2022
University of Minnesota researchers and their collaborators at the National Cancer Institute (NCI) investigated the role of a new intracellular checkpoint gene in regulating T-cell function against solid tumors.
Goldy vs. Cancer logo

Goldy vs. Cancer Day Returns to the Minnesota State Fair

August 17, 2022
The Masonic Cancer Center announces the return of Goldy vs. Cancer day at the Minnesota State Fair on Friday August 26, 2022 in the University of Minnesota Crossroads Building. It will be Goldy vs. Cancer as we #GOpherACure!
New logo image

U of M researchers discover protein that may be associated with better prognosis for women with ovarian cancer

July 19, 2022
Researchers from the University of Minnesota have discovered that a protein associated with metabolism, and formerly recognized as a potential therapeutic target for ovarian cancer, may instead be associated with a better prognosis for…
Announcing the MNCCTN Educational Campaign to increase knowledge and access to clinical trials

Minnesota Cancer Clinical Trials Network Announces Development of Collaborative Statewide Educational Campaign

July 6, 2022
The Minnesota Cancer Clinical Trials Network (MNCCTN) is pleased to announce the development of a statewide educational campaign about clinical trials. The educational campaign aims to increase awareness and understanding of clinical…

Research from the University of Minnesota Influences FDA Decision to Move Towards Lowering Nicotine Levels in Cigarettes

July 5, 2022
A decades-long collaborative research effort that determined that a lower dose of nicotine in cigarettes led to a reduction in cigarette smoking, exposure to carcinogens and dependence, and an increase in attempts to quit has finally paid…
Samir Khariwala

University of Minnesota Study Looks at Tobacco Use after Head and Neck Cancer Diagnosis

June 22, 2022
A new study out of the University of Minnesota looks at how posttreatment tobacco use in smokers with head and neck squamous cell carcinoma (HNSCC) changes over time. Tobacco use is well established as a carcinogen in HNSCC, meaning that…